TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

36.80$ +0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Cash Flow

Teva Pharma Industries Ltd (TEVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 411 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TEVA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,461 1,425 470 741 1,117 1,179 1,496 162 421 367 112 -227 325 538 305 273 307 331 -405 218 529 456 -49 123 543 973 -145 324 5.0 1,184 -124 103 693 575 -105 227 369 1,158 -40 411 1,898
577 332 480 577 527 528 507 479 474 382 443 450 413 416 399 382 381 395 376 305 329 320 323 358 321 306 304 300 283 266 272 259 259 269 244 251 249 260 239 241 989
31 41 40 35 31 27 30 47 45 33 34 30 35 20 30 32 29 38 31 29 26 33 24 39 26 36 32 30 31 28 28 32 29 34 34 38 34 51 43 40 168
2,153 -192 6,382 39 18,023 736 715 575 3,750 523 638 245 519 756 443 5,300 356 148 309 110 246 219 -330 12 1,638 683 683 -120
1,047 119 -463 -248 -44 392 -592 -676 -253 -302 -805 -251 272 -112 -666 -336 -625 -561 -1,076 -603 -202 180 559 354 93 250 -349 212 -227 326 -497 -10 317 -245 -700 -336 -561 229 -617 -164 -1,113
221 333 202 193 212 267 163 136 139 213 125 112 169 119 128 131 143 176 150 113 146 153 157 127 122 142 139 119 149 119 124 97 148 129 127 96 136 142 168 104 550
-32,301 -797 1,182 -392 -218 1,592 1,039 406 347 74 272 429 224 430 252 313 157 141 508 481 288 246 161 179 147 170 181 302 184 301 144 178 268 202 201 236 135 165 229 -491 38
405 410 411 410 188 152 22 10 1.2 22 52 52 52 52
1,013 0.0 -1,418 -22 -14 93 -52 -192 924 -734 -1,804 -598 2,402
26,251 -1,350 -189 -589 -4,477 -2,064 -51 -702 -455 -127 -32 -1,460 -244 -700 -1,056 -1,056 -124 -491 -1,175 -1,175 -500 -296 -296 -365 -708 -500 -500 -500 0.0 -685 -1,368 5.0 -451 0.0 -23 0.0 -474
25,372 -701 -1,768 -651 -825 -2,506 -2,091 -56 -705 -499 -189 -35 -1,461 -241 -700 -3.0 -1,057 -125 -493 -1.0 -1,177 -501 2.0 -338 -439 -713 -706 -55 -576 -576 -151 -966 0.0 -674 -1,744 6.0 -453 40 13 -1.0 -401
-5,427 -569 -88 -301 81 283 455 443 14 -93 191 192 -924 734 -171 598 -575 350 -434 693 -391 153 52 -159 167 576 -658 494 -420 977 -236 -733 1,061 -19 -1,603 464 42 1,353 185 -86 1,494
1,240 1,092 268 548 905 912 1,333 26 282 154 -13 -339 156 419 177 142 164 155 -555 105 383 303 -206 -4.0 421 831 -284 205 -144 1,065 -248 6.0 545 446 -232 131 233 1,016 -208 307 1,348

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?